1265 related articles for article (PubMed ID: 18537059)
1. Significance of dyslipidaemia in patients with heart failure of unexplained aetiology.
Skwarek M; Bilińska ZT; Mazurkiewicz Ł; Grzybowski J; Kruk M; Kurjata P; Piotrowski W; Ruzyłło W
Kardiol Pol; 2008 May; 66(5):515-22, discussion 523-4. PubMed ID: 18537059
[TBL] [Abstract][Full Text] [Related]
2. Prevalence and particularities of dyslipidaemia in subjects with coronary heart disease.
Agoşton-Coldea L; Zdrenghea D; Pop D; Crăciun A; Rusu ML; Mocan T
Rom J Intern Med; 2007; 45(4):341-7. PubMed ID: 18767409
[TBL] [Abstract][Full Text] [Related]
3. Triglyceride profile in dyslipidaemia of type 2 diabetes mellitus.
Khan SR; Ayub N; Nawab S; Shamsi TS
J Coll Physicians Surg Pak; 2008 May; 18(5):270-3. PubMed ID: 18541079
[TBL] [Abstract][Full Text] [Related]
4. High-density lipoprotein cholesterol levels and prognosis in advanced heart failure.
Mehra MR; Uber PA; Lavie CJ; Milani RV; Park MH; Ventura HO
J Heart Lung Transplant; 2009 Sep; 28(9):876-80. PubMed ID: 19716038
[TBL] [Abstract][Full Text] [Related]
5. A long-term follow-up study of serum lipid levels and coronary heart disease in the elderly.
Li JZ; Chen ML; Wang S; Dong J; Zeng P; Hou LW
Chin Med J (Engl); 2004 Feb; 117(2):163-7. PubMed ID: 14975195
[TBL] [Abstract][Full Text] [Related]
6. Cholesterol lipoproteins, triglycerides, rural-urban differences and prevalence of dyslipidaemia among males in Rajasthan.
Gupta R; Prakash H; Kaul V
J Assoc Physicians India; 1997 Apr; 45(4):275-9. PubMed ID: 12521083
[TBL] [Abstract][Full Text] [Related]
7. The association between fibrate use, change in high-density lipoprotein cholesterol, and the risk of cardiovascular disease: a retrospective chart review involving up to 8 years of follow-up.
Nichols GA; Koro CE; Chan W; Bowlin SJ; Sprecher DL
Clin Ther; 2006 Feb; 28(2):243-50. PubMed ID: 16678645
[TBL] [Abstract][Full Text] [Related]
8. Prognostic significance of serum cholesterol levels in patients with idiopathic dilated cardiomyopathy.
Christ M; Klima T; Grimm W; Mueller HH; Maisch B
Eur Heart J; 2006 Mar; 27(6):691-9. PubMed ID: 15821011
[TBL] [Abstract][Full Text] [Related]
9. A 52-week, randomized, open-label, parallel-group comparison of the tolerability and effects of pitavastatin and atorvastatin on high-density lipoprotein cholesterol levels and glucose metabolism in Japanese patients with elevated levels of low-density lipoprotein cholesterol and glucose intolerance.
Sasaki J; Ikeda Y; Kuribayashi T; Kajiwara K; Biro S; Yamamoto K; Ageta M; Kobori S; Saikawa T; Otonari T; Kono S
Clin Ther; 2008 Jun; 30(6):1089-101. PubMed ID: 18640465
[TBL] [Abstract][Full Text] [Related]
10. Hyperuricaemia predicts poor outcome in patients with mild to moderate chronic heart failure.
Jankowska EA; Ponikowska B; Majda J; Zymlinski R; Trzaska M; Reczuch K; Borodulin-Nadzieja L; Banasiak W; Ponikowski P
Int J Cardiol; 2007 Feb; 115(2):151-5. PubMed ID: 16782216
[TBL] [Abstract][Full Text] [Related]
11. Lability of serum low-density lipoprotein cholesterol levels during screening in subgroup of Air Force/Texas Coronary Atherosclerosis Prevention Study (AFCAPS/TexCAPS) cohort.
Clearfield MB; Weis SE; Willis JM; Vasenius KA; McConathy WJ
J Am Osteopath Assoc; 2002 Jul; 102(7):377-84. PubMed ID: 12138952
[TBL] [Abstract][Full Text] [Related]
12. Sustained improvement of dyslipidaemia in HAART-treated patients replacing stavudine with tenofovir.
Llibre JM; Domingo P; Palacios R; Santos J; Pérez-Elías MJ; Sánchez-de la Rosa R; Miralles C; Antela A; Moreno S;
AIDS; 2006 Jun; 20(10):1407-14. PubMed ID: 16791015
[TBL] [Abstract][Full Text] [Related]
13. Switching fibrate to statin in type 2 diabetic patients: consequences on lipid profile.
Meas T; Laloi-Michelin M; Virally M; Peynet J; Giraudeaux V; Kévorkian JP; Guillausseau PJ
Eur J Intern Med; 2009 Mar; 20(2):197-200. PubMed ID: 19327612
[TBL] [Abstract][Full Text] [Related]
14. Risk factors for heart failure in patients with one prior myocardial infarction episode.
Mocan T; Agoşton-Coldea L; Gatfossé M; Rosenstingl S; Mocan LC
Rom J Intern Med; 2008; 46(3):213-21. PubMed ID: 19366080
[TBL] [Abstract][Full Text] [Related]
15. Serum lipid profiles and their relationship to cardiovascular disease in the elderly: the PREV-ICTUS study.
Lozano JV; Pallarés V; Cea-Calvo L; Llisterri JL; Fernández-Pérez C; Martí-Canales JC; Aznar J; Gil-Guillén V; Redón J;
Curr Med Res Opin; 2008 Mar; 24(3):659-70. PubMed ID: 18218194
[TBL] [Abstract][Full Text] [Related]
16. Mixed dyslipidemia among patients using lipid-lowering therapy in French general practice: an observational study.
Van Ganse E; Laforest L; Burke T; Phatak H; Souchet T
Clin Ther; 2007 Aug; 29(8):1671-81. PubMed ID: 17919548
[TBL] [Abstract][Full Text] [Related]
17. Prevalence and extent of dyslipidemia and recommended lipid levels in US adults with and without cardiovascular comorbidities: the National Health and Nutrition Examination Survey 2003-2004.
Ghandehari H; Kamal-Bahl S; Wong ND
Am Heart J; 2008 Jul; 156(1):112-9. PubMed ID: 18585505
[TBL] [Abstract][Full Text] [Related]
18. Determinants of serum HDL-C level in a Tehran urban population: the Tehran Lipid and Glucose Study.
Azizi F; Raiszadeh F; Salehi P; Rahmani M; Emami H; Ghanbarian A; Hajipour R
Nutr Metab Cardiovasc Dis; 2002 Apr; 12(2):80-9. PubMed ID: 12189907
[TBL] [Abstract][Full Text] [Related]
19. Gender differences in the lipid profile of dyslipidemic subjects.
Kolovou GD; Anagnostopoulou KK; Damaskos DS; Bilianou HI; Mihas C; Milionis HJ; Kostakou PM; Cokkinos DV
Eur J Intern Med; 2009 Mar; 20(2):145-51. PubMed ID: 19327602
[TBL] [Abstract][Full Text] [Related]
20. Prevalence of dyslipidemia in the Iraqi adult population.
Mula-Abed WA; Chilmeran SK
Saudi Med J; 2007 Dec; 28(12):1868-74. PubMed ID: 18060219
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
